Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
A Agilent Technologies	$125.09 -0.1%	$118.72	$96.43 ▼ $153.84	$35.53B	1.24	1.96 million shs	2.50 million shs
DHR Danaher	$199.40 -2.2%	$201.97	$171.00 ▼ $279.90	$142.78B	0.75	4.16 million shs	3.47 million shs
QGEN Qiagen	$46.68 -0.5%	$48.70	$37.63 ▼ $51.88	$10.38B	0.64	1.40 million shs	1.93 million shs
TMO Thermo Fisher Scientific	$484.08 -0.7%	$456.01	$385.46 ▼ $627.88	$182.79B	0.75	2.43 million shs	1.21 million shs

The Next 7 Blockbuster Stocks for Growth Investors

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
A Agilent Technologies	-0.34%	+5.72%	+10.31%	+8.77%	-12.39%
DHR Danaher	-1.11%	-1.30%	+3.41%	+5.48%	-24.33%
QGEN Qiagen	+0.87%	-3.99%	-5.94%	+2.62%	+5.62%
TMO Thermo Fisher Scientific	-1.26%	-0.43%	+5.20%	+20.60%	-20.85%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
A Agilent Technologies	4.6211 of 5 stars	2.3	5.0	2.5	3.6	2.7	0.8	2.5
DHR Danaher	4.9268 of 5 stars	3.4	3.0	1.7	4.3	3.2	3.3	2.5
QGEN Qiagen	4.1877 of 5 stars	1.1	4.0	1.7	4.5	2.8	1.7	2.5
TMO Thermo Fisher Scientific	4.905 of 5 stars	3.4	3.0	2.5	4.1	2.9	2.5	2.5

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
A Agilent Technologies	2.50	Moderate Buy	$139.25	11.32% Upside
DHR Danaher	2.85	Moderate Buy	$246.35	23.54% Upside
QGEN Qiagen	2.27	Hold	$49.69	6.45% Upside
TMO Thermo Fisher Scientific	2.73	Moderate Buy	$589.38	21.75% Upside

Current Analyst Ratings Breakdown

Latest QGEN, A, DHR, and TMO Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
9/2/2025	DHR Danaher	Royal Bank Of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target		$241.00
9/2/2025	TMO Thermo Fisher Scientific	Royal Bank Of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target		$561.00
8/29/2025	A Agilent Technologies	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Equal Weight ➝ Equal Weight	$125.00
8/28/2025	A Agilent Technologies	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Outperform ➝ Outperform	$141.00 ➝ $142.00
8/28/2025	A Agilent Technologies	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$135.00 ➝ $140.00
8/28/2025	A Agilent Technologies	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	In-Line ➝ In-Line	$130.00 ➝ $128.00
8/18/2025	TMO Thermo Fisher Scientific	William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Outperform
8/7/2025	QGEN Qiagen	Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Hold ➝ Hold
8/7/2025	QGEN Qiagen	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Neutral ➝ Neutral	$48.00 ➝ $50.00
7/24/2025	TMO Thermo Fisher Scientific	Hsbc Global Res Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Strong-Buy ➝ Hold
7/24/2025	TMO Thermo Fisher Scientific	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Neutral ➝ Neutral	$460.00 ➝ $500.00

(Data available from 9/3/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
A Agilent Technologies	$6.51B	5.46	$6.22 per share	20.10	$22.42 per share	5.58
DHR Danaher	$24.01B	5.95	$10.58 per share	18.84	$73.10 per share	2.73
QGEN Qiagen	$1.98B	5.25	$3.22 per share	14.51	$15.77 per share	2.96
TMO Thermo Fisher Scientific	$42.88B	4.26	$29.50 per share	16.41	$133.67 per share	3.62

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
A Agilent Technologies	$1.29B	$4.26	29.36	20.57	3.91	17.97%	25.51%	12.94%	N/A
DHR Danaher	$3.90B	$4.70	42.43	23.27	2.87	14.21%	10.70%	6.85%	10/28/2025 (Estimated)
QGEN Qiagen	$83.59M	$1.69	27.58	18.97	2.57	18.30%	14.77%	8.87%	11/5/2025 (Estimated)
TMO Thermo Fisher Scientific	$6.34B	$17.29	28.00	18.94	2.63	15.24%	16.82%	8.38%	10/22/2025 (Estimated)

Latest QGEN, A, DHR, and TMO Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/27/2025	Q3 2025	A Agilent Technologies	$1.37	$1.37	N/A	$1.18	$1.67 billion	$1.74 billion
8/5/2025	Q2 2025	QGEN Qiagen	$0.60	$0.60	N/A	$0.44	$523.97 million	$533.54 million
7/23/2025	Q2 2025	TMO Thermo Fisher Scientific	$5.22	$5.36	+$0.14	$4.28	$10.68 billion	$10.86 billion
7/22/2025	Q2 2025	DHR Danaher	$1.64	$1.80	+$0.16	$0.77	$5.83 billion	$5.94 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
A Agilent Technologies	$0.99	0.79%	N/A	23.24%	9 Years
DHR Danaher	$1.28	0.64%	N/A	27.23%	2 Years
QGEN Qiagen	$0.25	0.54%	N/A	14.79%	N/A
TMO Thermo Fisher Scientific	$1.72	0.36%	N/A	9.95%	8 Years

Latest QGEN, A, DHR, and TMO Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
7/10/2025	TMO Thermo Fisher Scientific	quarterly	$0.43	0.4%	9/15/2025	9/15/2025	10/15/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
A Agilent Technologies	0.53	2.25	1.60
DHR Danaher	0.32	1.62	1.22
QGEN Qiagen	0.25	1.61	1.35
TMO Thermo Fisher Scientific	0.65	1.93	1.50

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
A Agilent Technologies	N/A
DHR Danaher	79.05%
QGEN Qiagen	70.00%
TMO Thermo Fisher Scientific	89.23%

Insider Ownership

Company	Insider Ownership
A Agilent Technologies	N/A
DHR Danaher	11.10%
QGEN Qiagen	9.00%
TMO Thermo Fisher Scientific	0.33%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
A Agilent Technologies	17,900	284.07 million	N/A	Optionable
DHR Danaher	63,000	716.05 million	635.85 million	Optionable
QGEN Qiagen	5,765	222.29 million	202.29 million	Optionable
TMO Thermo Fisher Scientific	125,000	377.61 million	376.37 million	Optionable

QGEN, A, DHR, and TMO Headlines

Recent News About These Companies

Strategic Sale: Joseph R Holmes Decides To Exercise Options Worth $88K At Thermo Fisher Scientific

5 hours ago | benzinga.com

Here’s Why Thermo Fisher Scientific (TMO) Traded Lower in Q2

September 3 at 8:30 AM | insidermonkey.com

Thermo Fisher Scientific Inc. $TMO Shares Acquired by First Manhattan CO. LLC.

September 3 at 8:03 AM | marketbeat.com

GW Henssler & Associates Ltd. Grows Stock Holdings in Thermo Fisher Scientific Inc. $TMO

September 3 at 7:51 AM | marketbeat.com

Thermo Fisher Scientific Inc. $TMO Shares Acquired by Braidwell LP

September 3 at 7:42 AM | marketbeat.com

DRW Securities LLC Has $427,000 Stock Position in Thermo Fisher Scientific Inc. $TMO

September 3 at 6:12 AM | marketbeat.com

Vident Advisory LLC Has $2.86 Million Stake in Thermo Fisher Scientific Inc. $TMO

September 3 at 5:38 AM | marketbeat.com

Why Thermo Fisher Scientific Stock Tumbled Today

September 2 at 7:30 PM | fool.com

Thermo Fisher Scientific Completes Acquisition of Sanofi’s Ridgefield, New Jersey Site

September 2 at 11:53 AM | bakersfield.comB

Thermo Fisher Scientific's Valuation: Assessing Growth Potential After New Facility and Nalgene Product Launches

September 2 at 11:53 AM | finance.yahoo.com

Flputnam Investment Management Co. Sells 5,399 Shares of Thermo Fisher Scientific Inc. $TMO

September 2 at 9:49 AM | marketbeat.com

Royal Bank of Canada Sells 47,855 Shares of Thermo Fisher Scientific Inc. $TMO

September 2 at 9:39 AM | marketbeat.com

Cyrus J. Lawrence LLC Cuts Stake in Thermo Fisher Scientific Inc. $TMO

September 2 at 8:11 AM | marketbeat.com

Solventum Completes Sale of its Purification & Filtration Business to Thermo Fisher Scientific Inc.

September 2 at 8:00 AM | prnewswire.com

MAI Capital Management Has $19.69 Million Stock Holdings in Thermo Fisher Scientific Inc. $TMO

September 2 at 7:52 AM | marketbeat.com

Is Thermo Fisher Scientific Stock Underperforming the Dow?

September 1 at 6:34 PM | finance.yahoo.com

Brasada Capital Management LP Invests $4.51 Million in Thermo Fisher Scientific Inc. $TMO

September 1 at 7:36 AM | marketbeat.com

Baird Financial Group Inc. Cuts Stake in Thermo Fisher Scientific Inc. $TMO

September 1 at 6:27 AM | marketbeat.com

Thermo Fisher Scientific (NYSE:TMO) Raised to "Buy" at Wall Street Zen

September 1 at 3:43 AM | marketbeat.com

Thermo Fisher Scientific Inc. $TMO Shares Sold by The Manufacturers Life Insurance Company

August 31 at 7:24 AM | marketbeat.com

Magnetar Financial LLC Has $7.01 Million Position in Thermo Fisher Scientific Inc. $TMO

August 31 at 7:15 AM | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

QGEN, A, DHR, and TMO Company Descriptions

Agilent Technologies NYSE:A

$125.09 -0.12 (-0.10%)

Closing price 03:59 PM Eastern

Extended Trading

$124.80 -0.30 (-0.24%)

As of 07:10 PM Eastern

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment focuses on genomics, nucleic acid contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership, and biomolecular analysis businesses. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and offers services portfolio, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, and consulting services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.

Danaher NYSE:DHR

$199.40 -4.39 (-2.15%)

Closing price 03:59 PM Eastern

Extended Trading

$199.59 +0.19 (+0.09%)

As of 07:17 PM Eastern

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies and reagents, and particle counting and characterization; microscopes; protein consumables; industrial filtration products; and genomic medicines, such as custom nucleic acid products, plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX and SCIEX brands. The Diagnostics segment offers chemistry, immunoassay, microbiology, and automation systems; and molecular, acute care, and pathology diagnostics products. This segment also provides clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is based in Washington, the District of Columbia.

Qiagen NYSE:QGEN

$46.68 -0.24 (-0.52%)

Closing price 03:59 PM Eastern

Extended Trading

$46.71 +0.03 (+0.07%)

As of 06:25 PM Eastern

QIAGEN NV is a holding company, which engages in the provision of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. The company sample technologies isolate and process DNA, RNA, and proteins from blood, tissue, and other materials. The firm assay technologies make these biomolecules visible and ready for analysis. Its bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. The company was founded by Detlev H. Riesner and Metin Colpan on April 29, 1996, and is headquartered in Venlo, the Netherlands.

Thermo Fisher Scientific NYSE:TMO

$484.08 -3.45 (-0.71%)

Closing price 03:59 PM Eastern

Extended Trading

$483.48 -0.59 (-0.12%)

As of 06:48 PM Eastern

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time